Novel Fluticasone Propionate and Salmeterol Fixed-Dose Combination Nano-Encapsulated Particles Using Polyamide Based on L-Lysine

One of the key challenges in developing a dry powder inhaler (DPI) of an inhalable potent fixed-dose combination (FDC) is the ability of the formulation to generate an effective and reproducible aerosol able to reach the lower parts of the lungs. Herein, a one-step approach is presented to expedite...

Full description

Bibliographic Details
Published in:Pharmaceuticals
Main Authors: Mohammad H. Alyami, Eman Zmaily Dahmash, Dalia Khalil Ali, Hamad S. Alyami, Hussien AbdulKarim, Samar A. Alsudir
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Subjects:
fluticasone propionate
salmeterol xinafoate
polyamide
respiratory drug delivery
L-lysine
nanocapsules
Online Access:https://www.mdpi.com/1424-8247/15/3/321

Internet

https://www.mdpi.com/1424-8247/15/3/321

Similar Items